SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Alan Turing — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientAlan Turing
Date of birth1912-06-23
IdentifiersMRN HR-ML007-SYN-TD; SSN (made up) 000-07-6290
Document date1953-10-20
AuthorRupert Hallam, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic preventive visit; no new complaints. [S]

History of Present Illness

Mr. Turing is a 41-year-old mathematician who comes for his periodic preventive visit two weeks after his six-month review. He completed the health risk assessment before the visit. His ankle recovered within three weeks of the August visit; he took ibuprofen for four days and is back to about 40 km a week. His depression is in remission on bupropion XL 150 mg with monthly psychotherapy sessions, and his testosterone has been normal since August. The breast tissue is no longer tender. He has had no suicidal thoughts. He has not had HIV or STI testing since moving here and would like it today. He has had one new male partner in the past three months and uses condoms most of the time. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 41
Safety eventsNo falls, emergency visits, or hospital stays this year
MedicinesBupropion XL 150 mg and cholecalciferol 1,000 units daily; ibuprofen for four days in August
Active conditionsDepression in remission; small residual gynecomastia; ankle sprain resolved
Sexual healthOne new male partner in three months; condoms most of the time; asks for HIV and STI testing

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, much better than in the spring
PsychosocialSees friends weekly; back with his running club; no current legal proceedings
TobaccoNever used tobacco
Alcohol and drugsTwo or three drinks a week (AUDIT-C 2); no drug use
Physical activityRunning about 40 km a week with weekly strength work
NutritionRegular meals; calcium from dairy most days
SleepAbout seven hours a night
Sexual healthOne new male partner in the past three months; condoms most of the time; no symptoms
Activities of daily livingIndependent
Instrumental activities of daily livingIndependent
Home safetySmoke detectors working; no firearms in the home
Hearing and visionNo concerns

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight steady; no fever or fatigue
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo hearing loss, sore throat, or mouth ulcers
CardiovascularNegativeNo chest pain or palpitations when running
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo abdominal pain, change in bowel habit, or rectal symptoms
GenitourinaryNegativeNo urethral discharge, dysuria, or genital sores; libido and erections back to his usual
MusculoskeletalNegativeAnkle recovered
IntegumentaryNegativeNo rash or new skin lesions
NeurologicalNegativeNo headaches or numbness
PsychiatricNegativeMood good; PHQ-9 3 with item 9 scored 0; no suicidal thoughts
BreastNegativeNo breast pain, new lump, or nipple discharge

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cholecalciferol 1,000 units (25 mcg) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1953-04-14activeS
Bupropion extended-release 150 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1953-06-09activeS
Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 5 daysOne tablet up to three times a day with food, for no more than 5 daysOral route1953-08-25 to 1953-08-30completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1953-10-20Body height178cmS
1953-10-20Body weight68.5kgS
1953-10-20Body mass index (BMI) [Ratio]21.6kg/m2S
1953-10-20Systolic blood pressure116mm[Hg]S
1953-10-20Diastolic blood pressure72mm[Hg]S
1953-10-20Heart rate54/minS
1953-10-20Respiratory rate14/minS
1953-10-20Body temperature36.6CelS
1953-10-20Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1953-10-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1953-10-20Total score [AUDIT-C]2{score}S
1953-10-20Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
1953-10-20Cholesterol in HDL [Mass/volume] in Serum or Plasma62mg/dL>=40 mg/dLNormalS
1953-10-20Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation104mg/dL<=129 mg/dLNormalS
1953-10-20Triglyceride [Mass/volume] in Serum or Plasma80mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 1953-10-20; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell and lean; weight 68.5 kg, BMI 21.6
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm at 54 per minute, as expected in a trained runner; no murmur
RespiratoryClear
BreastExamined with his agreement: a soft disc of glandular tissue about 2 cm behind the left nipple and 1 cm behind the right, non-tender; no discrete mass, skin change, nipple discharge, or axillary nodes
AbdomenSoft and non-tender
GenitourinaryOffered and declined today; no symptoms
SkinNo rash or suspicious lesions
MusculoskeletalRight ankle stable with full range of motion
Mental statusRelaxed, humorous, and engaged; euthymic; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Bilateral gynecomastia, tender, about 4 cm of firm glandular tissue behind each nipple, after a year of high-dose estrogen; synthetic modern diagnosis linked to the documented breast growth from his hormone treatmentactiveconfirmed N62S — Synthetic modern diagnosis. That the hormone treatment caused breast growth is reported in the sources (D, mentioned once in his own words); the examination findings are synthetic.
Suppressed testosterone and gonadotropins from exogenous estrogen (drug-induced hypogonadotropic hypogonadism), with low libido, erectile difficulty, and fatigueresolvedconfirmed E23.1S — Synthetic consequence of high-dose estrogen, which suppresses LH and FSH; recovery is expected once it stops.
Adverse effects of high-dose estrogen given for a year without free and informed consent, as the alternative to imprisonmentactiveconfirmed T38.5X5AS — Synthetic modern framing of the documented hormone treatment imposed after his conviction (D); in the modern episode it is recorded as iatrogenic harm.
Major depressive disorder, single episode, moderate, after prosecution and coerced hormone treatment; synthetic modern diagnosis (no depression diagnosis is documented in his lifetime)activeconfirmed F32.1S — Synthetic modern diagnosis. That he sought Jungian analysis after the trial is documented (D); calling his state then a depressive illness is a retrospective interpretation (R).
Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL)resolvedconfirmed E55.9S — Synthetic finding of the bone-health workup.
Right lateral ankle sprain while trail running, able to bear weight, Ottawa ankle rules negative; resolvedresolvedconfirmed S93.401AS — Synthetic sprain at an unscheduled visit, chosen to teach the Ottawa ankle rules and how to protect a depression plan that relies on running; it does not echo any documented injury.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressureCompleted today116/72 mmHg
Cholesterol and statin decisionCompleted todayTotal cholesterol 182, HDL 62, LDL 104, triglycerides 80 mg/dL; ten-year risk under 2 percent, so no statin; repeat in five years
Diabetes screeningNot indicatedBMI 21.6 with no other risk factors; screening is for adults 35 to 70 with overweight or obesity
HIV screeningOrderedHIV antigen and antibody test drawn today with his consent
Syphilis, gonorrhea, and chlamydia testingOrderedSyphilis serology and urine, pharyngeal, and rectal NAATs by site of exposure, drawn today with his consent; yearly while sexually active, more often if his risk changes
Hepatitis C screeningOrderedOne-time antibody test drawn today
Hepatitis B screening and vaccinationOrderedHBsAg, core antibody, and surface antibody drawn today; vaccinate if not immune
HIV preexposure prophylaxisNot indicatedDiscussed as routine care; he does not meet the indications now; to be revisited at any visit he wishes
Colorectal cancer screeningNot indicatedBegins at 45; no family history recorded
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever used tobacco
Depression screening and monitoringCompleted todayPHQ-9 3 in continuation treatment; item 9 scored 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 2
Influenza vaccine, this seasonCompleted todayGiven today with his consent
COVID-19 vaccine, this seasonDueRecommended; he will have it at a pharmacy next week
Hepatitis A vaccineDueRecommended for men who have sex with men; first dose at his next visit after he has thought it over
HPV vaccineDueShared decision for adults 27 to 45; he will decide at his next visit
Tetanus, diphtheria, and pertussis boosterUp to dateTdap five years ago
Dental examinationDueNo dental visit since moving here; he will book one

Immunizations given today: Influenza vaccine, 1953-1954 season [S]

Guideline basis: APA Guidelines for Psychological Practice With Sexual Minority Persons (2021); Sexually Transmitted Infections Treatment Guidelines: Men Who Have Sex with Men (2021); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Results by secure message within a week. COVID-19 vaccine at a pharmacy. Hepatitis A and HPV vaccine decisions at the next visit. Depression review in about two months. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, a close friend, and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think and work, and that no treatment should ever be given to him without his own agreement or, if he cannot speak, his agent's. He wants full treatment for reversible illness. He asked that his records, including his sexual orientation and the history of the estrogen he was given, be shared only with clinicians treating him. The plan will be revisited yearly. [S]